Dr.ย Davidย Tan
BSc (Hons), MBBS (Hons), MRCP (UK), PhD, FRCP (Edin)
Senior Consultant Medical Oncologist
corporate_fareNational University Cancer Institute, Singapore
David Tan
BSc (Hons), MBBS (Hons), MRCP (UK), PhD, FRCP (Edin)
Dr. David Shao Peng Tan is a Senior Consultant Medical Oncologist at the National University Cancer Institute, Singapore (NCIS), specialising in gynaecologic cancers including ovarian, endometrial and cervical cancers. He is also Associate Professor at the Yong Loo Lin School of Medicine, NUS, and Principal Investigator at the Cancer Science Institute, NUS.
Trained in London and at the Princess Margaret Cancer Centre in Toronto, Dr. Tan brings deep expertise in precision oncology, immuno-oncology and early-phase clinical trial development to every case he evaluates. His clinician-scientist profile means patients benefit from evidence-based systemic therapy planning directly informed by his research in biomarkers and novel anticancer therapeutics. He holds an active drug development and Phase I trial programme for gynaecologic malignancies, and his Google Scholar profile records more than 12,000 citations with an h-index of 52. He is additionally Senior Consultant in the Department of Oncology โ Medical & Radiation at Ng Teng Fong General Hospital.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Tan at NCIS Singapore.
Why Consider Dr. David Shao Peng Tan?
Dr. Tan combines specialist gynaecologic oncology care with active translational research, making him particularly relevant for patients with ovarian, endometrial or cervical cancer seeking a highly informed second opinion or systemic treatment plan.
Areas of Specialisation
Expert medical oncology for gynaecologic cancers, with a focus on precision treatment and clinical research
Dr. Tan's clinical and research work spans the full range of gynaecologic malignancies, with particular depth in ovarian cancer biology, biomarker-guided treatment selection, immuno-oncology and early-phase oncology trial design.
Gynaecologic Oncology
Medical oncology treatment for ovarian, endometrial and cervical cancers including systemic therapy planning and clinical trial access.
- arrow_rightSystemic treatment planning for epithelial ovarian cancer
- arrow_rightManagement of recurrent ovarian cancer including clear cell histology
- arrow_rightBiomarker-guided treatment decisions and response monitoring
- arrow_rightMedical oncology for endometrial cancer
- arrow_rightSystemic therapy planning for advanced or recurrent cervical cancer
- arrow_rightMultidisciplinary care coordination for complex gynaecologic cases
Precision Oncology & Immuno-Oncology
Biomarker-driven treatment selection and immunotherapy evaluation for eligible patients with gynaecologic malignancies.
- arrow_rightMolecular profiling and biomarker-guided treatment planning
- arrow_rightIntegration of translational research into clinical decision-making
- arrow_rightCheckpoint inhibitor and immunotherapy evaluation for suitable patients
- arrow_rightClinical trial assessment for novel immunotherapeutic agents
Drug Development & Clinical Trials
Phase I and early-phase trial design and participation for novel anticancer therapeutics in gynaecologic malignancies.
- arrow_rightPhase I trial design and participation
- arrow_rightEligibility assessment for investigational drug programmes
- arrow_rightDevelopment of novel therapeutic agents for gynaecologic cancers
- arrow_rightTranslational research connecting laboratory findings to clinical outcomes
Procedures Performed
Systemic cancer treatment and clinical trial services for gynaecologic malignancies
Dr. Tan is a medical oncologist. His clinical services encompass systemic treatment planning, precision oncology, immuno-oncology and clinical trial evaluation for women with gynaecologic cancers.
Systemic Cancer Treatment
Medical OncologyChemotherapy and systemic treatment planning for ovarian, endometrial and cervical cancers.
Targeted & Precision Therapy
Targeted TherapyBiomarker-driven treatment selection for eligible patients with gynaecologic malignancies.
Immuno-Oncology
Medical OncologyImmunotherapy evaluation and treatment planning for suitable gynaecologic cancer patients.
Clinical Trial Evaluation
Complex DiseaseEligibility assessment for Phase I and early-phase investigational drug trials in gynaecologic oncology.
Second Opinion Review
Second OpinionExpert second-opinion review for complex gynaecologic cancer cases, including recurrent or treatment-resistant disease.
Research & Publications
Peer-reviewed research in gynaecologic oncology, biomarkers and early-phase trials
Dr. David Shao Peng Tan is a prolific clinician-scientist whose research focuses on gynaecologic cancers, precision oncology and drug development. His Google Scholar profile records more than 12,000 citations and an h-index of 52.
Dr. Tan is a Principal Investigator at the Cancer Science Institute, NUS, with an ongoing research programme in gynaecologic cancer biomarkers and novel therapeutic agents.
Education & Training
Dr. Tan completed his undergraduate and medical training at the University of London, undertook specialist oncology research training at the Institute of Cancer Research, London, and completed fellowship training at the Princess Margaret Cancer Centre, University of Toronto. He is a Fellow of the Royal College of Physicians of Edinburgh.
Clinical Experience
Dr. David Tan joined the National University Cancer Institute, Singapore as a Consultant in 2012 following fellowship training in London and Toronto. He was promoted to Senior Consultant in January 2019 and concurrently holds positions as Associate Professor at the Yong Loo Lin School of Medicine, NUS, and Principal Investigator at the Cancer Science Institute, NUS.
Languages & International
Dr. David Tan consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting Dr. Tan.
CancerFax can coordinate professional medical interpreter support for international patients where required.
How CancerFax Helps You Access Dr. David Tan
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. David Tan's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. David Tan's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. David Tan before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. David Tan's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. David Tan's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. David Tan's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. David Shao Peng Tan
Dr. David Tan specialises in gynaecologic cancers, with a primary focus on ovarian cancer, endometrial cancer and cervical cancer. NCIS Singapore verifies his special interests in gynaecological cancers and the development of novel anticancer therapeutic agents.
Dr. Tan is a Senior Consultant at the National University Cancer Institute, Singapore (NCIS), part of the National University Health System. He also holds a Senior Consultant designation at Ng Teng Fong General Hospital's Department of Oncology โ Medical & Radiation.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Tan, subject to hospital availability and case acceptance. Please submit your medical records through CancerFax to begin the process.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare a structured case summary, and coordinate the next steps with NCIS, subject to availability. A second-opinion request should include pathology reports, imaging, treatment history and relevant test results.
Yes. Dr. Tan's clinical interests include drug development and Phase I clinical trials for gynaecologic cancers. He has been associated with multicentre research in recurrent ovarian clear cell carcinoma, including a randomised trial evaluating durvalumab for this condition. Eligibility for any specific trial depends on the patient's current disease status and protocol criteria.
Dr. Tan holds a BSc with First Class Honours, MBBS, MRCP (UK), PhD and FRCP Edinburgh, all from London-based institutions. He is Associate Professor at the Yong Loo Lin School of Medicine, National University of Singapore, and Principal Investigator at the Cancer Science Institute, NUS.
Connect with David Tan Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.